Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population

@GoldenTatsu @Grxit @rataverdestudio This is a study done in 2021 about cardiovacular risk attached to gender affirming hormone therapy https://t.co/nYlZRxic4I

@NaanBeenAri @GifferRetuns2 Then that's a male. If you keep male genitalia, even if some idiot practitioner is willing to sell you estrogen for breast development, then you'll be treated as a male with a high risk for a cardiac event. https://t.co/ud1e7V

@inconv_Estelle @FellySapphire @AriDrennen You can't stay on topic, can you? https://t.co/7XtbFAFyOX

@MadzzzDraws Source? https://t.co/fqafSoI9q1 This states that trans women only have as high a risk as cis men.